{
    "code": "06016190",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06016190",
    "time": "2019-12-13 03:44:21",
    "許可證字號": "衛署醫器輸字第016190號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/03\/21",
    "發證日期": "95\/03\/21",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHAS0601619009",
    "中文品名": "希摩西爾第二凝固因子缺乏血漿",
    "英文品名": "HemosIL Factor II deficient plasma",
    "效能": "此試劑是以免疫去除法去除血漿中的第二因子，提供在IL血漿凝固系統上配合凝血？原試劑當做凝固因子受質之用。",
    "醫器規格": "#08466050：5 x 1 mL。\r\n增加規格 #0020012200：10 x 1 mL。\r\n註銷規格：#08466050。",
    "劑型": "",
    "包裝": "",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器主類別二": [
        ""
    ],
    "醫器主類別三": "",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "640110B420  台灣沃芬有限公司",
        "申請商地址": "臺北市內湖區堤頂大道二段501號4樓",
        "主製造廠": "",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060161900001-108.5.21-仿單-108-05-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06016190&Seq=003&Type=9"
        },
        {
            "title": "060161900002-108.5.21-外盒-108-05-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06016190&Seq=003&Type=8"
        }
    ]
}